Navigation Links
How nice, brown rice: Study shows rice bran lowers blood pressure in rats

Thousands of years ago, humans began scrubbing off and discarding the outer layer of long-grain rice, preferring the polished white kernel beneath. Now, for the first time, scientists in Japan have shown that this waste product of rice processing, called rice bran, significantly lowers blood pressure in rats whose hypertension resembles that of humans.

The team reports their findings in the March 8 issue of the Journal of Agricultural and Food Chemistry, published by the American Chemical Society, the world’s largest scientific society.

A commonly prescribed class of drugs called ACE inhibitors dilates the arteries of hypertensive patients and thus decreases their risk of stroke, heart attack and kidney disease. But the drugs can also carry side effects: chronic cough, allergic reactions, dizziness, even kidney problems.

What if some component of our diet could work in similar fashion, with few or no side effects? Researchers at Tohoku University and Japan’s National Research Institute of Brewing demonstrated that adding rice bran to the diets of hypertensive, stroke-prone rats lowered the animals?systolic blood pressure by about 20 percent and, via the same mechanism, inhibited angiotensin-1 converting enzyme, or ACE.

“There’s much work being done on various bran fractions to nail down any health benefits,?says the journal’s editor, James Seiber, Ph.D., who is also director of the U.S. Department of Agriculture’s Western Regional Research Center in Davis, Calif. “This particular paper caught my attention for two reasons: the potential of bringing a waste product like rice bran into beneficial use, and the way the group went about their study with good controlled experiments using an appropriate model.?/p>

It’s still not clear whether simply eating more brown rice, which retains some of its bran, would reduce the risk of heart disease. However, previous research in humans, as well as animals with high cholesterol, does sug gest that certain fractions of rice bran can lower levels of unhealthy LDL cholesterol.

The Tohoku study adds antihypertensive activity to the picture, along with a host of other biochemical markers that track blood glucose (implicated in diabetes), lipid profile, kidney function and the harmful effects of free radicals.

For example, high levels of a marker called 8-OHdG indicate biological stress and genetic damage due to oxygen-based free radicals. The researchers found that rice bran, which contains various forms of the antioxidant Vitamin E, markedly lowered the rats?levels of the peptide 8-OHdG.

“Oxidative stress plays an important role in the initiation and progression of cardiovascular diseases,?explained lead author Ardiansyah [editor note: name is correct as written, there is no first name], a Ph.D. candidate at the university’s School of Agricultural Science.

He added one more element to the research that is new: using enzymes to clip components of rice bran from its cell walls, rather than extracting a fraction with ethanol. “I think enzymatic treatment will be more suitable for applications if we’d like to use [rice bran as] functional food,?he said.

The researchers?next step is to elucidate the mechanisms by which specific components of rice bran inhibit ACE and lower cholesterol.


'"/>

Source:American Chemical Society


Related biology news :

1. Chemicals in brown algae may protect against skin cancer
2. A more powerful and efficient engine for rice: the C3-C4 challenge
3. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
4. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
5. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
6. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
7. Study Links Ebola Outbreaks To Animal Carcasses
8. Breakthrough Microarray-based Technology for the Study of Cancer
9. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
10. Study finds more than one-third of human genome regulated by RNA
11. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, ... company focused on the licensing, development and commercialization of ... Pharm,s Best Company in North America ... the award based on the FDA approval ... (grapiprant tablets), ENTYCE ® (capromorelin oral solution) and ...
(Date:1/20/2017)... ... , ... The two newest companies to join the University City Science Center’s ... from The Wistar Institute, and Sanguis, launched by a trio of students from the ... Vironika is developing a treatment for a chronic viral infection and its associated diseases, ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
Breaking Biology Technology: